Irwin Naturals Inc.

IWIN

CA46414Q1054

Pharmaceuticals

End-of-day quote Canadian Securities Exchange Other stock markets 03:30:00 07/05/2024 am IST			5-day change	1st Jan Change
0.3 ^USD	-.--%		-.--%	+57.89%

29/03	Irwin Naturals, Inc. Announces CFO Changes	CI
29/03	Irwin Naturals, Inc. Announces Directors Changes	CI

Irwin Naturals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022

November 30, 2022 at 07:01 pm IST

Irwin Naturals Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was USD 22.02 million compared to USD 23.67 million a year ago. Net loss was USD 0.673 million compared to USD 1.61 million a year ago.
For the nine months, sales was USD 66.43 million compared to USD 74.4 million a year ago. Net income was USD 0.668 million compared to USD 5.23 million a year ago.

Latest news about Irwin Naturals Inc.

Irwin Naturals, Inc. Announces CFO Changes	29/03	CI
Irwin Naturals, Inc. Announces Directors Changes	29/03	CI
Tranche Update on Irwin Naturals, Inc.'s Equity Buyback Plan announced on September 26, 2022.	23/11	CI
Irwin Naturals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23/11	CI
Transcript : Irwin Naturals, Inc. - Shareholder/Analyst Call	28/23/28
Irwin Naturals, Inc.'s Equity Buyback announced on September 26, 2022, has closed with 81,000 shares, representing 3.74% for CAD 0.21 million.	26/23/26	CI
Irwin Naturals Swings to Loss in Q2, Revenue Grows	28/23/28	MT
Irwin Naturals Announces Goodwill Impairment for the Second Quarter Ended June 30, 2023	26/23/26	CI
Tranche Update on Irwin Naturals, Inc.'s Equity Buyback Plan announced on September 26, 2022.	26/23/26	CI
Irwin Naturals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	26/23/26	CI
Irwin Naturals Inc. Announces Licensing and Supply Agreement with The Hive Laboratory, LLC	29/23/29	CI
Irwin Naturals, Inc. Appoints Sheri Orlowitz as New Director	01/23/01	CI
Irwin Naturals, Inc. Reports Impairment Charges for the First Quarter Ended March 31, 2023	01/23/01	CI
Tranche Update on Irwin Naturals, Inc.'s Equity Buyback Plan announced on September 26, 2022.	30/23/30	CI
Irwin Naturals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	30/23/30	CI
Tranche Update on Irwin Naturals, Inc.'s Equity Buyback Plan announced on September 26, 2022.	25/23/25	CI
Irwin Naturals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	25/23/25	CI
Irwin Naturals, Inc. Auditor Raises 'Going Concern' Doubt	25/23/25	CI
Irwin Naturals Inc. Announces Directorate Changes	02/23/02	CI
Irwin Naturals Inc. terminated agreement to acquire Assets of Tri-Cities Infusion & Wellness Clinic, PLLC.	02/23/02	CI
Irwin Naturals Launches New Product in Canada	24/23/24	MT
Irwin Naturals Brief: Says Cannabis Products Launch Nationwide in Canada	24/23/24	MT
Irwin Naturals Inc. Announces the Release of Irwin Naturals Cannabis' New CBD 25mg Softgels in Canada	24/23/24	CI
Irwin Naturals Closes Purchase of Ketamine Media	22/23/22	MT
Irwin Naturals Inc. completed the acquisition of Keta Media, LLC.	17/23/17	CI

Chart Irwin Naturals Inc.

Duration

Period

More charts

Company Profile

Irwin Naturals Inc. (Irwin) is a nutraceutical company. The Company is engaged in distributing cannabidiol (CBD) products in mass-market and health food chain stores across the United States. Irwin's portfolio of herbal products is available in more than 100,000 retail doors across North America. The Company's full range of Vitamin, CBD, and Supplements features over 100 products, created to address mood and brain function, better sleep, sports performance, sexual health, immune support, weight management, women's health and men's health. The Company's ketamine clinic, Emergence, is an infusion clinic that offers intravenous (IV) ketamine for the treatment of depression, post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), anxiety, bipolar disorder, migraines, and multiple chronic pain conditions such as complex regional pain syndrome (CRPS), reflex sympathetic dystrophy (RSD) and fibromyalgia.

Sector

Pharmaceuticals

Calendar

26/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
IRWIN NATURALS INC.	+57.89%	741K
CARDINAL HEALTH, INC.	-1.52%	24.18B
SINOPHARM GROUP CO. LTD.	+4.89%	8.46B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+8.55%	8.34B
HUADONG MEDICINE CO., LTD	-23.71%	7.64B
H. LUNDBECK A/S	+15.20%	5.33B
GALENICA AG	+2.68%	4.12B
EBOS GROUP LIMITED	-6.90%	3.92B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+5.56%	3.89B
CHINA NATIONAL MEDICINES CORPORATION LTD.	+18.80%	3.54B

Pharmaceuticals Wholesale